Fapon Biopharma Introduces FP008 at Biotech Showcase: A Safer and More Effective Immunotherapy for Refractory Cancers SAN FRANCISCO, Jan. 2, 2025 /PRNewswire/ — Fapon Biopharma, an innovator in… CISION PRNewswireJanuary 2, 2025
ATFX 2024 Recap: A Year of Expansion, Innovation, and Global Leadership HONG KONG, Jan. 2, 2025 /PRNewswire/ — As 2024 concludes, ATFX has… CISION PRNewswireJanuary 2, 2025
Press ReleaseThailand Rings in 2025 at CentralwOrld – The Times Square of Asia – with a Dazzling Fireworks Spectacle BANGKOK, Jan. 2, 2025 /PRNewswire/ — Bangkok came alive on New Year’s… CISION PRNewswireJanuary 2, 2025
Press ReleaseKuCoin Launches KuCoin Pay, a Merchant Solution Leading the Future of Crypto Payments VICTORIA, Seychelles, Jan. 2, 2025 /PRNewswire/ — In a significant leap forward… CISION PRNewswireJanuary 2, 2025
Press ReleaseLattePanda Mu: High-Performance Micro x86 Compute Module with Intel 8-Core N305 CPU and 16GB RAM Now Available SHANGHAI, Jan. 2, 2025 /PRNewswire/ — The LattePanda Team is excited to announce… CISION PRNewswireJanuary 2, 2025
Annual economic work conference presents roadmap for 2025 BEIJING, Jan. 2, 2025 /PRNewswire/ — A news report from Beijing Review: The… CISION PRNewswireJanuary 2, 2025
FDA Grants Orphan Drug Designation to MicuRx's MRX-5 for NTM Infections SHANGHAI, Jan. 2, 2025 /PRNewswire/ — Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx"，688373.SH)… CISION PRNewswireJanuary 2, 2025
Press ReleaseKuCoin Advances the "Menstrual Equity Project", Benefiting 4,000 Women in the Bahamas NASSAU, Bahamas, Jan. 2, 2025 /PRNewswire/ — On December 31, 2024, the… CISION PRNewswireJanuary 2, 2025
